Tessellate BIO
About:
Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques.
Website: https://tessellatebio.com
Top Investors: Forbion Capital Partners, BioGeneration Ventures
Description:
Tessellate BIO is a biotechnology business in the preclinical stage that focuses on advanced Synthetic Lethality techniques. It develops precision oncology methods to treat tumors with significant unmet medical needs.
Total Funding Amount:
8M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Naarden, Noord-Holland, The Netherlands
Founded Date:
2020-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-10-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai